Australia markets closed

Twist Bioscience Corporation (0ME.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
31.32+0.64 (+2.09%)
As of 09:59AM CET. Market open.
Full screen
Previous close30.68
Open31.24
Bid31.34 x 10000
Ask32.56 x 10000
Day's range31.24 - 31.32
52-week range10.24 - 38.52
Volume670
Avg. volume30
Market cap1.878B
Beta (5Y monthly)1.64
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing

    SOUTH SAN FRANCISCO, Calif., March 05, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced European Union (EU) in vitro diagnostic regulations (IVDR) compliant Twist Precision Dx next-generation sequencing (NGS) Products.

  • Business Wire

    Twist Bioscience to Present at Upcoming Investor Conferences

    SOUTH SAN FRANCISCO, Calif., February 22, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:

  • Business Wire

    Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., February 07, 2024--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) ("Twist" or the "Company"), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 122,400 restricted stock units ("RSUs") to 36 recently hired individuals as an inducement material to their acceptance of employment with Twist. The employment i